| 1 |
Sarcopenia: revised European consensus on definition and diagnosis
Alfonso José Cruz-Jentoft et al. · Age and Ageing
Open access |
24 Sep 2018 |
14,151 |
| 2 |
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
Clotilde Théry et al. · Journal of Extracellular Vesicles
Open access382 authors |
23 Nov 2018 |
11,535 |
| 3 |
Diagnosis and management of dementia with Lewy bodies
Ian Grant McKeith et al. · Neurology
|
27 Dec 2005 |
5,092 |
| 4 |
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Achim Rittmeyer et al. · The Lancet
Open access |
12 Dec 2016 |
4,817 |
| 5 |
2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Frank H J van den Hoogen et al. · Arthritis & Rheumatism
Open access |
3 Oct 2013 |
3,458 |
| 6 |
European Guidelines for Obesity Management in Adults
Volkan Demirhan Yumuk, Constantine Tsigos, Martin Fried et al. · Obesity Facts
Open access |
2015 |
3,432 |
| 7 |
Tethyan evolution of Turkey: A plate tectonic approach
A. M. Celâl Şengör, Yücel Yılmaz · Tectonophysics
|
Jun 1981 |
3,405 |
| 8 |
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
Tony S.K. Mok et al. · The Lancet
Open access258 authors |
4 Apr 2019 |
3,392 |
| 9 |
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
Johann Sebastian De Bono, Stéphane Marie. Oudard, Mustafa Özgüroğlu et al. · The Lancet
|
Oct 2010 |
3,328 |
| 10 |
Clinical diagnostic criteria for dementia associated with Parkinson's disease
Murat Emre et al. · Movement Disorders
|
31 May 2007 |
3,081 |
| 11 |
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
David H Adams et al. · New England Journal of Medicine
Open access |
4 Jul 2018 |
3,046 |
| 12 |
Mapping genomic loci implicates genes and synaptic biology in schizophrenia
Vassily Vladimirovich Trubetskoy et al. · Nature
Open access613 authors |
8 Apr 2022 |
2,894 |
| 13 |
Novel Total Antioxidant Capacity Index for Dietary Polyphenols and Vitamins C and E, Using Their Cupric Ion Reducing Capability in the Presence of Neocuproine: CUPRAC Method
Reşat Apak, Kubilay Güçlü, Mustafa Özyürek et al. · Journal of Agricultural and Food Chemistry
|
25 Nov 2004 |
2,812 |
| 14 |
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
Irene Litvan, Jennifer G. Goldman, Alexander I. Tröster et al. · Movement Disorders
Open access |
24 Jan 2012 |
2,583 |
| 15 |
Disruptions of Topological Chromatin Domains Cause Pathogenic Rewiring of Gene-Enhancer Interactions
Darío G. Lupiáñez et al. · Cell
Open access |
May 2015 |
2,334 |
| 16 |
Contrasting Computational Models of Mate Preference Integration Across 45 Countries
Daniel Conroy‐Beam et al. · Scientific Reports
Open access107 authors |
15 Nov 2019 |
1,776 |
| 17 |
The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission1
Ingmar Blümcke et al. · Epilepsia
Open access |
10 Nov 2010 |
1,764 |
| 18 |
Acid Mine Drainage (AMD): causes, treatment and case studies
Ata Akçıl, Soner Koldas · Journal of Cleaner Production
|
30 Apr 2005 |
1,716 |
| 19 |
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
Giuseppe Mancia et al. · Journal of Hypertension
|
21 Oct 2009 |
1,659 |
| 20 |
Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2)
Patrick Revy et al. · Cell
Open access |
Sep 2000 |
1,653 |
| 21 |
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
Stephan L. Zuchner et al. · Nature Genetics
|
4 Apr 2004 |
1,593 |
| 22 |
EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria
Seza Özen et al. · Annals of the Rheumatic Diseases
Open access |
22 Apr 2010 |
1,459 |
| 23 |
Genetic diagnosis by whole exome capture and massively parallel DNA sequencing
Murim Choi, Ute I. Scholl, Weizhen Ji et al. · Proceedings of the National Academy of Sciences
Open access |
27 Oct 2009 |
1,364 |
| 24 |
Pyogenic Bacterial Infections in Humans with MyD88 Deficiency
Horst von Bernuth et al. · Science
Open access |
31 Jul 2008 |
1,293 |
| 25 |
A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease
Carl J. Pepine, Eileen Handberg, Rhonda M. Cooper‐DeHoff et al. · JAMA
|
2 Dec 2003 |
1,293 |
| 26 |
Forensic Taphonomy: The Postmortem Fate of Human Remains
Mehmet Yaşar İşcan, Barbara Q. McCabe · Forensic Science International
|
Feb 2001 |
1,273 |
| 27 |
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Torsten Zuberbier et al. · Allergy
Open access |
18 Sep 2021 |
1,253 |
| 28 |
Comparative Evaluation of Various Total Antioxidant Capacity Assays Applied to Phenolic Compounds with the CUPRAC Assay
Reşat Apak, Kubilay Güçlü, Birsen Demirata et al. · Molecules
Open access |
19 Jul 2007 |
1,243 |
| 29 |
Rivastigmine for Dementia Associated with Parkinson's Disease
Murat Emre, Dag Aarsland, Alberto Albanese et al. · New England Journal of Medicine
Open access |
9 Dec 2004 |
1,230 |
| 30 |
Association of Cardiometabolic Multimorbidity With Mortality
Emanuele Di Angelantonio et al. · JAMA
Open access |
7 Jul 2015 |
1,189 |
| 31 |
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
Harry L.A. Janssen, Monika van Zonneveld, Hakan Şentürk et al. · The Lancet
|
2005 |
1,165 |
| 32 |
International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology
Ravindra L. Mehta et al. · The Lancet
|
13 Mar 2015 |
1,164 |
| 33 |
Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019
on behalf of Lifting The Burden: the Global Campaign against Headache, Timothy J. Steiner, Lars Jacob Stovner et al. · The Journal of Headache and Pain
Open access |
Dec 2020 |
1,113 |
| 34 |
Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force
Bruno Dubois et al. · Movement Disorders
Open access |
15 Dec 2007 |
1,099 |
| 35 |
Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide
Frédéric Houssiau et al. · Arthritis & Rheumatism
Open access |
Aug 2002 |
1,080 |
| 36 |
Immune Responses in Healthy and Allergic Individuals Are Characterized by a Fine Balance between Allergen-specific T Regulatory 1 and T Helper 2 Cells
Mübeccel Akdis, Johan Verhagen, Alison Taylor et al. · The Journal of Experimental Medicine
Open access |
Jun 2004 |
1,054 |
| 37 |
International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: A Task Force report from the ILAE Commission on Diagnostic Methods
Ingmar Blümcke et al. · Epilepsia
|
20 May 2013 |
1,038 |
| 38 |
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Andrea Cossarizza et al. · European Journal of Immunology
Open access436 authors |
Oct 2019 |
1,014 |
| 39 |
Mutations in Kir2.1 Cause the Developmental and Episodic Electrical Phenotypes of Andersen's Syndrome
Nikki M. Plaster et al. · Cell
Open access |
May 2001 |
1,008 |
| 40 |
Emergence of Oxacillinase-Mediated Resistance to Imipenem inKlebsiella pneumoniae
Laurent Poirel, Claire Héritier, Venus Tolün et al. · Antimicrobial Agents and Chemotherapy
Open access |
24 Dec 2003 |
996 |
| 41 |
EULAR recommendations for the management of primary small and medium vessel vasculitis
Chetan B. Mukhtyar, Loı̈c Guillevin, Maria Cinta Cid et al. · Annals of the Rheumatic Diseases
Open access |
15 Apr 2008 |
994 |
| 42 |
Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI
Justin E. Davies et al. · New England Journal of Medicine
Open access |
18 Mar 2017 |
982 |
| 43 |
Antioxidant Activity/Capacity Measurement. 1. Classification, Physicochemical Principles, Mechanisms, and Electron Transfer (ET)-Based Assays
Reşat Apak, Mustafa Özyürek, Kubilay Güçlü et al. · Journal of Agricultural and Food Chemistry
Open access |
4 Jan 2016 |
959 |
| 44 |
FCC-ee: The Lepton Collider
Asmâa Abada et al. · The European Physical Journal Special Topics
Open access1,362 authors |
Jun 2019 |
950 |
| 45 |
Histopathological Findings in Brain Tissue Obtained during Epilepsy Surgery
Ingmar Blümcke et al. · New England Journal of Medicine
Open access |
25 Oct 2017 |
947 |
| 46 |
Summary of the Recommendations on Sexual Dysfunctions in Men
Francesco Montorsi et al. · The Journal of Sexual Medicine
|
29 Oct 2010 |
944 |
| 47 |
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
Mine Durusu Tanrıöver et al. · The Lancet
Open access |
Jul 2021 |
934 |
| 48 |
Evidence-based analysis of risk factors for postoperative nausea and vomiting
Christian C. Apfel, Felix Matthias Heidrich, S. Jukar-Rao et al. · British Journal of Anaesthesia
Open access |
3 Oct 2012 |
882 |
| 49 |
Long-term side effects of glucocorticoids
Merih Oray, Khawla Abu Samra, Nazanin Ebrahimiadib et al. · Expert Opinion on Drug Safety
|
20 Jan 2016 |
874 |
| 50 |
Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III
David B. Simon et al. · Nature Genetics
|
Oct 1997 |
873 |